NHS Digital Data Release Register - reformatted
British Society Of Gastroenterology
Project 1 — DARS-NIC-344511-H6N5B
Opt outs honoured: N
Sensitive: Non Sensitive
When: 2017/03 — 2017/05.
Legal basis: Section 251 approval is in place for the flow of identifiable data
Categories: Anonymised - ICO code compliant
- Hospital Episode Statistics Admitted Patient Care
- Hospital Episode Statistics Accident and Emergency
First quarterly feedback – From January 2017 The provision of information on service activity, cost, clinical treatments and patient outcomes to participating hospitals will enable effective benchmarking and comparison of local services against other IBD services. The information will improve patient care by enabling participating organisations to identify their own strengths and weaknesses and plan improvements to their patient pathways and service organisation. First Annual Report – September 2017 At present, information on IBD is scarce at national level. As such, policy makers are unable to take an informed view on standards and clinical practice across the country and are unable to develop evidence based policies based on national information. The development of the annual report is intended to fill this gap in knowledge. This will provide a national overview of the current state and historic trends in health utilisation and outcomes for IBD; enabling national clinical guidelines and standards to be reviewed and improved with the benefit of population-based evidence to supplement consensus clinical opinion. When the previous DARS application was made, the intention had been to produce a first Registry annual report in June 2016. However, the Registry development was significantly delayed by the decision of NHS England in 2015 to cease funding the Inflammatory Bowel Disease Audit as part of the NCAPOP programme. This required the Registry to adapt its planned developments to collaborate with the IBD Audit during a transition year (2016-17) funded by NHS England specifically to ensure the transfer of the national biologics audit data collection and IBD quality improvement into the IBD Registry. Registry research project – December 2016 The first approved Registry Research Project entitled ‘Maximising the value of the UK IBD Registry for service delivery, audit and research’ has been funded by Crohn's and Colitis UK as a two-year project after peer-review by their Research Committee. The project is being conducted by the University of Liverpool in collaboration with participating hospitals and aims to (a) generate metrics of care based on the combined HES/IBD dataset for cases entered into the Registry. A substantial part of the project focuses on developing the analytical methods to maximize the use of HES data, firstly in isolation from Registry data (to define methodologies for analysing pseudonymised HES data alone) and secondly using the combined HES/IBD dataset. The Registry can apply these methods in its future cycles of data collection and reporting. Publication of these methods used in IBD is likely to support improved use of HES data for IBD benchmarking within the NHS and have an academic value for other researchers involved in similar projects in the future. Connected to output: Registry Research Project Publications. Publications and presentations are expected throughout 2016. The project will formally report to the funding body in October 2016 and the project is funded through to September 2017. This work will drive improvements in the methodology and outputs of the registry increasing the value that is obtained from the data held by the registry; this will ensure that the other activities undertaken using data held by the registry are of a higher quality and there for have a greater positive impact on patient care. These improvements in methodology may also be of value outside of the registry.
Output 1: Trust Level Feedback Report Publication Intent: Available to Trusts that are participating in the Registry. Target Date: From September 2016 Detail: To provide aggregated information at site level on both the ‘Registered’ (patients identified in the IBD Registry) and ‘Unregistered’ (patients identified by clinical codes submitted to HES). Suppression: Suppressed in line with the HES analysis guide ****** Update for the renewal This work has progressed well during the year following a clearly defined path designed to engage clinicians in the process of developing an agreed methodology. Sample reports were provided to a small set of participating hospitals for comment by the IBD teams on whether the aggregated figures derived from the analysis had face validity and were useful in clinical service evaluation. Comments were received and taken into account in the development of the next stage, which is to provide all IBD teams in participating NHS Trusts in England with an example St Elsewhere’s report to seek their views on the format of the report, suggestions for further development and also to invite them to request a similar output for their Trust. Alongside this is a short survey to collect some organisational data necessary to make the individual reports more accurate and useful. This consultation will take place in January 2017, and the hope is to provide tailored reports in April/May 2017. **************** Output 2: Annual Registry Report. Publication Intent: Published Target Date: September 2017 Detail: This is a report into the performance of the NHS on IBD and will provide aggregated information down to site level on both the ‘Registered’ (patients identified in the IBD Registry) and ‘Unregistered’ (patients identified by clinical codes submitted to HES). Suppression: Suppressed in line with the HES analysis guide Output 3: Registry Research Project Publications ‘Maximising the value of the UK IBD Registry for service delivery, audit and research’ Publication Intent: Published Target Date: From June 2016 onwards Detail: Aims to (a) develop IBD care metrics based on HES data alone, HES/IBD Registry data and IBD Registry data alone, and (b) use the Registry systems to capture the full secondary-care IBD population of participating hospitals and validate a sample of the records reported to the Registry. Suppression: Suppressed in line with the HES analysis guide ****************** Update for renewal This element of the research is progressing well. There have been two publications as abstracts at the BSG Annual Meeting in June 2016: one concerning mortality and one methodological. BSG 2016 - Abstract Submission Inflammatory Bowel Disease BSG16-ABS-1756 TRENDS IN MORTALITY FOR IBD PATIENTS ADMITTED AS AN EMERGENCY TO ENGLISH HOSPITALS: A 10- YEAR ANALYSIS OF ROUTINE ADMINISTRATIVE DATA BSG 2016 - Abstract Submission Gastroenterology service: development, delivery, IT BSG16-ABS-1952 DEVELOPMENT OF INFORMATICS TOOLS FOR THE UK IBD REGISTRY USING ROUTINE DATA: PROFILING OF NATIONAL-LEVEL HOSPITAL ACTIVITY FOR IBD PATIENTS IN ENGLAND Further abstracts will be submitted in February 2017 for the BSG June 2017 meeting. The work is currently focusing on rates of Unplanned admissions and A&E attendances as potential indicators of less than good care, which could in future be presented alongside some key elements of resource and organisation such as availability of IBD nurses and use of IBD-specific clinics. The research is also looking at healthcare utilisation before and after prescription of biological therapies - some early results on both aspects will form the basis of the 2017 abstracts. ************
NHS Digital (Clinical Audit and Registry Management Service) are data processors for the IBD Registry. They collect and hold identifiable data from providers, which they anonymise with the IBD Study ID before providing it to the IBD Registry. NHS Digital (HES) are provided with the IBD Study ID, NHS Number, Date of Birth, Gender and Postcode by NHS Digital (CARMS). NHS Digital link the IBD Registry data with the HES data attaching the provided StudyID where appropriate. The requested HES dataset (and IBD Study ID) is provided to the University of Liverpool , who already hold the Registry data. The University of Liverpool will analyse the HES/IBD data and will produce the aggregate outputs for the three purposes listed above. As required the University of Liverpool will enhance the combined HES/IBD dataset with non-identifiable reference data sets such as labels and groupings for diagnosis codes, or indices of deprivation. Those outputs will have small numbers suppressed in line with the HES Analysis Guide. Two sensitive data items are requested - consultant code and registered GP code. Consultant code is to assist in identifying the correct records for inclusion in the analysis for each IBD Team to produce aggregated information on workload at team level. The GP code is to enable the patient's activity to be allocated in the analysis to the the responsible CCG so that for the first time ever the IBD workload for each CCG can be accurately identified. The two data items will not be used to identify individual consultants or individual GPs in any of the report outputs or publications.
To link the registry of Inflammatory Bowel Disease (IBD) patients in England to HES and in doing so produce a source of high quality information that will be able to provide more accurate identification of the health outcomes and health care utilisation of IBD patients. Outputs from this registry would then be used for feeding into national service development planning and fulfilling national audit, improving IBD standards and quality improvement benchmarks. There are currently three identified outputs which can be categorised as follows: 1. A Trust level feedback report 2. Annual registry report 3. A research project entitled ‘Maximising the value of the UK IBD Registry for service delivery, audit and research’